Research Analysis of Mead Johnson Nutrition Company (NYSE:MJN)

Mead Johnson Nutrition Company (NYSE:MJN) belonging to the Consumer Staples sector has declined -0.36% and closed its last trading session at $84.08.

The company reported its EPS on 01/26/2017. Currently, the stock has a 1 Year Price Target of $80.4.

The consensus recommendation, according to Zacks Investment research, is 2.5. The scale runs from 1 to 5 with 1 recommending Strong Buy and 5 recommending a Strong Sell. The Stock had a 2.6 Consensus Analyst Recommendation 30 Days Ago, whereas 60 days ago and 90 days ago the analyst recommendations were 2.6 and 2.25 respectively.

Mead Johnson Nutrition Company on 01/26/2017 reported its EPS as $0.78 with the analysts projecting the EPS of the stock as $0.81. The company beat the analyst EPS Estimate with the difference of $-0.03. This shows a surprise factor of -3.7%.

Many analysts have provided their estimated foresights on Mead Johnson Nutrition Company Earnings, with 11 analysts believing the company would generate an Average Estimate of $0.8. Whereas they predicted High and Low Earnings Estimate as $0.85 and $0.72 respectively. While in the same Quarter Previous year, the Actual EPS was $0.87.

Analysts are also projecting an Average Revenue Estimate for Mead Johnson Nutrition Company as $910.3 Million in the Current Quarter. This estimate is provided by 9 analysts. The High Revenue estimate is predicted as 941 Million, while the Low Revenue Estimate prediction stands at 895 Million. The company’s last year sales total was 962.1 Million.

For the Current Quarter, the growth estimate for Mead Johnson Nutrition Company is -8%, while for the Next Quarter the stock growth estimate is -10.2%. In the past 5 years, the stock showed growth of 3.72% per annum. While for the next 5 years, the growth estimate is 2.24%.

The Company got Upgrade by Berenberg on 2-Feb-17 from Sell to Hold.

Insider Trades for Mead Johnson Nutrition Company show that the latest trade was made on 30 Oct 2016 where Catalano (Anna Cheng), the Director completed a transaction type “Sell” in which 656 shares were traded at a price of $74.99.

Over the period of 6 months, Insider Purchases show a total of 6 transaction in which 31500 shares were traded. 6 Insider Sales transactions were made totaling 24848 shares traded.

10 analysts projected Price Targets for Mead Johnson Nutrition Company. The analysts believe that the company stock price could grow as high as $95. The Low Price target projection by analysts is $72 and the Mean Price Target is $80.4.

Mead Johnson Nutrition Company (NYSE:MJN) has the market capitalization of $15.53 Billion. The company rocked its 52-Week High of $94.4 on Jul 26, 2016 and touched its 52-Week Low of $66.66 on Feb 9, 2016. The stock has Return on Assets (ROA) of 13.3 percent. Return on Equity (ROE) stands at -99.3% and Return on Investment (ROI) of 0 percent.

The stock is currently showing YTD performance of 18.82 Percent. The company has Beta Value of 1.38 and ATR value of 2.52. The Weekly and Monthly Volatility stands at 2.19% and 2.23%.

Company profile:

Mead Johnson, a global leader in pediatric nutrition, develops, manufactures, markets and distributes more than 70 products in over 50 markets worldwide. The company’s mission is to nourish the world’s children for the best start in life. The Mead Johnson name has been associated with science-based pediatric nutrition products for over 100 years. The company’s Enfa family of brands, including Enfamil® infant formula, is the world’s leading brand franchise in pediatric nutrition.